Reversal of the antiaggregant effect of ticagrelor in combination with acetylsalicylic acid, using normal platelets
Year: 2019
Type: dissertation
Abstract: Ticagrelor, a platelet P2Y 12 receptor antagonist, decreases thrombotic events in patients with coronary artery disease but increases the risk of bleeding. All antidote is not yet available. Platelet transfusion has the potential to reverse the antiplatelet effect cl ticagrelor and reduce bleeding. This thesis reports on an in vitro study which shows that donor platelets increase the aggregation of tlcagrelor-treated platelets. The extent of the increase is determined by the time since the previous dose of ticagrelor and the quantity of donor platelets. Using the in vitro results, estimates of the effect of platelet transfusion on platelet aggregation are made.
Author: Kruger, Paul
Institution: The University of Western Australia
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3015667699
